Discontinuation report FOLIC ACID INJECTION USP
Report ID | 82956 |
Drug Identification Number | 00816086 |
Brand name | FOLIC ACID INJECTION USP |
Common or Proper name | FOLIC ACID |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | FOLIC ACID |
Strength(s) | 5MG |
Dosage form(s) | LIQUID |
Route of administration | INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS |
Packaging size | 10ML vial) |
ATC code | B03BB |
ATC description | VITAMIN B12 AND FOLIC ACID |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2019-10-31 |
Actual discontinuation date | |
Remaining supply date | 2019-10-31 |
Discontinuation status | To be discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2019-05-01 | French | Compare |
v1 | 2019-05-01 | English | Compare |
Showing 1 to 2 of 2